These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20199131)

  • 1. A case of torsades de pointes induced by severe QT prolongation after an overdose of eperisone and triazolam in a patient receiving nifedipine.
    Yamagiwa T; Amino M; Morita S; Yamamoto R; Saito T; Inokuchi S
    Clin Toxicol (Phila); 2010 Feb; 48(2):149-52. PubMed ID: 20199131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentration of eperisone hydrochloride correlates with QT interval.
    Yamagiwa T; Morita S; Amino M; Miura N; Saito T; Inokuchi S
    Am J Emerg Med; 2014 Jan; 32(1):75-7. PubMed ID: 24135462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QTc prolongation and Torsade de Pointes induced by extreme eperisone overdose.
    Haga Y; Kamijo Y; Yoshizawa T; Hanazawa T; Yokoyama N; Kishino T
    Clin Toxicol (Phila); 2020 Jan; 58(1):67-68. PubMed ID: 30896264
    [No Abstract]   [Full Text] [Related]  

  • 4. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
    Isbister GK; Balit CR; Macleod D; Duffull SB
    J Clin Psychopharmacol; 2010 Aug; 30(4):391-5. PubMed ID: 20531221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
    Othong R; Devlin JJ; Kazzi ZN
    Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case series of drug-induced long QT syndrome and Torsade de Pointes.
    Tong KL; Lau YS; Teo WS
    Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination of drug-induced torsades de pointes with overdrive pacing.
    Charlton NP; Lawrence DT; Brady WJ; Kirk MA; Holstege CP
    Am J Emerg Med; 2010 Jan; 28(1):95-102. PubMed ID: 20006210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citalopram induced torsade de pointes, a rare life threatening side effect.
    Kanjanauthai S; Kanluen T; Chareonthaitawee P
    Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy.
    Elbey MA; Cil H; Onturk E; Islamoglu Y
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):100-2. PubMed ID: 22338554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.
    Abi-Gerges N; Philp K; Pollard C; Wakefield I; Hammond TG; Valentin JP
    Fundam Clin Pharmacol; 2004 Apr; 18(2):139-51. PubMed ID: 15066127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of torsade de pointes from the QT interval: analysis of a case series of amisulpride overdoses.
    Joy JP; Coulter CV; Duffull SB; Isbister GK
    Clin Pharmacol Ther; 2011 Aug; 90(2):243-5. PubMed ID: 21716272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Torsades de pointes and prolongation of the duration of QT interval after injection of droperidol].
    Guy JM; André-Fouet X; Porte J; Bertrand M; Lamaud M; Verneyre H
    Ann Cardiol Angeiol (Paris); 1991 Nov; 40(9):541-5. PubMed ID: 1776799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone.
    Kounas SP; Letsas KP; Sideris A; Efraimidis M; Kardaras F
    Pacing Clin Electrophysiol; 2005 May; 28(5):472-3. PubMed ID: 15869686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
    Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
    J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
    Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diphenhydramine induced QT prolongation and torsade de pointes: An uncommon effect of a common drug.
    Husain Z; Hussain K; Nair R; Steinman R
    Cardiol J; 2010; 17(5):509-11. PubMed ID: 20865683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Torsade de Pointes with T wave alternans in a patient receiving moderate dose of chlorpromazine: report of a case].
    Ochiai H; Kashiwagi M; Usui T; Oyama Y; Tokita Y; Ishikawa T
    Kokyu To Junkan; 1990 Aug; 38(8):819-22. PubMed ID: 2218093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: a case control pilot study.
    Hinterseer M; Thomsen MB; Beckmann BM; Pfeufer A; Schimpf R; Wichmann HE; Steinbeck G; Vos MA; Kaab S
    Eur Heart J; 2008 Jan; 29(2):185-90. PubMed ID: 18156612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.